Skip to main content

ADHD Meds May Help Control Opioid Use Disorder in Pregnancy

Medically reviewed by Carmen Pope, BPharm. Last updated on June 25, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, June 25, 2024 -- Psychostimulants may help opioid use disorder (OUD) outcomes in pregnant women, according to a study published online June 11 in Nature Mental Health.

Kevin Y. Xu, M.D., M.P.H., from the Washington University School of Medicine in St. Louis, and colleagues used U.S. multistate administrative data to examine the risks and benefits of attention-deficit/hyperactivity disorder (ADHD) medication among 3,247 pregnant women initiating OUD treatment, with 5 percent receiving psychostimulants.

The researchers found that compared to peers not receiving psychostimulants, individuals receiving psychostimulants had greater buprenorphine (adjusted relative risk, 1.81) but lower methadone initiation (adjusted relative risk, 0.39). Among psychostimulant recipients who initiated buprenorphine, lower buprenorphine discontinuation was seen among those receiving psychostimulants versus nonrecipients (adjusted hazard ratio, 0.77). Person-days (defined by psychostimulant fills) were associated with fewer substance use disorder-related admissions versus days without fills in within-person case-crossover analyses (odds ratio, 0.50).

"These findings highlight important potential benefits of pharmacologically treating ADHD with stimulants in pregnant people with concomitant OUD and ADHD," the authors write. "Future studies are warranted to clarify pregnancy and neonatal outcomes when treating this specific population to further inform share decision-making."

One author disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted June 2024

Read this next

Youth Deaths Attributable to Synthetic Opioids Alone Increasingly Predominant

THURSDAY, May 29, 2025 -- Among U.S. youth, overdose deaths attributable to synthetic opioids alone are increasingly predominant, according to a study published online May 20 in...

Exercise May Provide Protection for Childhood Psychiatric Conditions

THURSDAY, May 15, 2025 -- Physical activity (PA) and participation in organized sports may offer protective effects against childhood psychiatric conditions, according to a study...

Previous Estimates of Illicit Opioid Use in the United States Underreported

WEDNESDAY, May 14, 2025 -- Illicit opioid use may be higher than previously reported in the United States, according to a study published online May 9 in JAMA Health...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.